| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.13 | 0.008 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.12 | 0.009 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |